参考文献/References:
[1] 张旭,史小荣.联合检测肿瘤标志物在卵巢癌诊断中的应用进展[J].中国当代医药,2013,20(10):23-24,31.DOI:10.3969/j.issn.1674-4721.2013.10.009.Zhang X,Shi XR.Application of combined measurement of tumor markers in the diagnosis of ovarian cancer[J].Chin Mod Med,2013,20(10):23-24,31.
[2] Ashworth T.A case of cancer in which cells similar to those in the tumors were seen in the blood after death[J].Aust Med J,1986,14:146-149.
[3] 刘志勇,李宝江.乳腺癌新辅助化疗中循环肿瘤细胞的动态变化及疗效观察[J].中国肿瘤临床,2013,40(23):1431-1435.DOI:10.3969/j.issn.1000-8179.20131252.Liu ZY,Li BJ.Efficacy of neoadjuvant chemotherapy on breast cancer and dynamic changes of circulating tumor cells[J].Chin J Clin Oncol,2013,40(23):1431-1435.
[4] Alva A,Friedlander T,Clark M,et al.Circulating tumor cells as potential biomarkers in bladder cancer[J].J Urol,2015,194(3):790-798.DOI:10.1016/j.juro.2015.02.2951.
[5] Kolostova K,Broul M,Schraml J,et al.Circulating tumor cells in localized prostate cancer:isolation,cultivation in vitro and relationship to T-stage and Gleason score[J].Anticancer Res,2014,34(7):3641-3646.
[6] Poveda A,Kaye SB,Mccormack R,et al.Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer[J].Gynecol Oncol,2011,122(3):567-572.DOI:10.1016/j.ygyno.2011.05.028.
[7] Ning N,Zhan T,Zhang Y,et al.Improvement of specific detection of circulating tumor cells using combined CD45 staining and fluorescence in situ hybridization[J].Clin Chim Acta,2014,433:69-75.DOI:10.1016/j.cca.2014.02.019.
[8] Pearl ML,Zhao Q,Yang J,et al.Prognostic analysis of invasive circulating tumor cells(iCTCs)in epithelial ovarian cancer[J].Gynecol Oncol,2014,134(3):581-590.DOI:10.1016/j.ygyno.2014.06.013.
[9] 李世超,姜军.乳腺癌循环肿瘤细胞生物学特性的研究进展[J].中华肿瘤防治杂志,2012,19(16):1272-1275.DOI:10.16073/j.cnki.cjcpt.2012.16.004.Li SC,Jiang J.Progress in biological characteristics of circulating breast-tumor cells[J].Chin J Cancer Prev Treat,2012,19(16):1272-1275.
[10] Vona G,Sabile A,Louha M,et al.Isolation by size of epithelial tumor cells:a new method for the immunomorphological and molecular characterization of circulatingtumor cells[J].Am J Pathol,2000,156(1):57-63.DOI:10.1016/S0002-9440(10)64706-2.
[11] Choi H,Kim KB,Jeon CS,et al.A label-free DC impedance-based microcytometer for circulating rare cancer cell counting[J].Lab Chip,2013,13(5):970-977.DOI:10.1039/c2lc41376k.
[12] 刘慧颖,殷正丰.上皮间质转化与循环肿瘤细胞[J].肿瘤,2013,33(9):837-840.DOI:10.3781/j.issn.1000-7431.2013.09.015.Liu HY,Yin ZF.Epithelial-mesenchymal transition and circulating tumor cells[J].Tumor,2013,33(9):837-840.
[13] 曾晶,陈东妮,徐进.角蛋白与肿瘤[J].中国细胞生物学学报,2012,34(5):485-492.Zeng J,Chen DN,Xu J.Keratins and Tumors[J].Chin J Cell Biol,2012,34(5):485-492.
[14] 孙凯旋,陈曦,陈说,等.CK7和CA125在人卵巢癌的表达及意义[J].解剖科学进展,2014,20(3):237-239,245.Sun KX,Chen X,Chen S,et al.The expression and significance of CK7 and CA125 in human ovarian cancer[J].Prog Anat Sci,2014,20(3):237-239,245.
[15] 孙红敏,苑中甫.原发及转移性卵巢癌组织中绒毛蛋白、细胞角蛋白7及20的表达[J].郑州大学学报:医学版,2007,42(2):345-347.DOI:10.3969/j.issn.1671-6825.2007.02.053.Sun HM,Yuan ZF.Expression of villin,CK7,and CK20 in primary and metastatic ovarian carcinoma tissue[J].J Zhengzhou Univ(Med Sci),2007,42(2):345-347.
[16] Judson PL,Geller MA,Bliss RL,et al.Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer[J].Gynecol Oncol,2003,91(2):389-394.DOI:10.1016/j.ygyno.2003.08.004.
[17] Ntouroupi TG,Ashraf SQ,Mcgregor SB,et al.Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope[J].Br J Cancer,2008,99(5):789-795.DOI:10.1038/sj.bjc.6604545.
[18] Aktas B,Kasimir-Bauer S,Heubner M,et al.Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy[J].Int J Gynecol Cancer,2011,21(5):822-830.DOI:10.1097/IGC.0b013e318216cb91.
[19] 蒋胜,李力,张玮,等.ERCC1基因mRNA表达水平在卵巢上皮性癌组织中的意义[J].实用妇产科杂志,2009,25(11):661-663.DOI:10.3969/j.issn.1003-6946.2009.11.011.Jiang S,Li L,Zhang W,et al.ERCC1 mRNA expression level as a prognostic factor for epithelial ovarian cancer[J].J Pract Obstet Gynecol,2009,25(11):661-663.
[20] Kuhlmann JD,Wimberger P,Bankfalvi A,et al.ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for Platinum resistance[J].Clin Chem,2014,60(10):1282-1289.DOI:10.1373/clinchem.2014.224808.
[21] Obermayr E,Castillo-Tong DC,Pils D,et al.Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance——a study of the OVCAD consortium[J].Gynecol Oncol,2013,128(1):15-21.DOI:10.1016/j.ygyno.2012.09.021.
[22] He W,Kularatne SA,Kalli KR,et al.Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands[J].Int J Cancer,2008,123(8):1968-1973.DOI:10.1002/ijc.23717.
[23] Feng H,Ghazizadeh M,Konishi H,et al.Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas[J].Jpn J Clin Oncol,2002,32(12):525-529.DOI:10.1093/jjco/hyf111.
[24] 曾新红.卵巢癌组织中GST-π和muc1基因的表达及临床意义[D].北京:中国人民解放军军医进修学院,2004.Zeng XH.GST-π and muc1 gene expression in ovarian carcinoma tissue and their clinical significance[D].Beijing:Chin PLA Postgraduate Med School,2004.
[25] Wang L,Ma J,Liu F,et al.Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance[J].Gynecol Oncol,2007,105(3):695-702.DOI:10.1016/j.ygyno.2007.02.004.
[26] 陆松梅,周琦,张娜,等.EPCAM、MUC16免疫磁珠制备及循环肿瘤细胞检测[J].免疫学杂志,2015,31(6):517-522 DOI:10.13431/j.cnki.immunol.j.20150110Lu SM,Zhou Q,Zhang N,et al.EPCAM and MUC16 immunomagnetic beads preparation and circulating tumor cells detection[J].J Immunol,2015,31(6):517-522.
[27] He S,Li P,Chen X,et al.Fluid biopsy for circulating tumor cells in an occult ovarian cancer patient exhibiting bilateral supraclavicular lymph node metastases:A case report[J].Oncol Lett,2013,6(2):448-452.DOI:10.3892/ol.2013.1364.
[28] Fan T,Zhao Q,Chen JJ,et al.Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer[J].Gynecol Oncol,2009,112(1):185-191.DOI:10.1016/j.ygyno.2008.09.021.
[29] Liu JF,Kindelberger D,Doyle C,et al.Predictive value of circulating tumor cells(CTCs)in newly-diagnosed and recurrent ovarian cancer patients[J].Gynecol Oncol,2013,131(2):352-356.DOI:10.1016/j.ygyno.2013.08.006.
[30] Marth C,Kisic J,Kaern J,et al.Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis[J].Cancer,2002,94(3):707-712.DOI:10.1002/cncr.10250.
相似文献/References:
[1]王立凯,黄丽娟,潘学继,等.人附睾蛋白4单克隆抗体与免放试剂盒的制备及其对卵巢癌诊断的临床价值探讨[J].国际放射医学核医学杂志,2016,40(3):183.[doi:10.3760/cma.j.issn.1673-4114.2016.03.005]
Wang Likai,Huang Lijuan,Pan Xueji,et al.Preparation of monoclonal antibodies and immunoradiometric assay kit against human epididymis protein 4 and its clinical value in diagnosis of ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):183.[doi:10.3760/cma.j.issn.1673-4114.2016.03.005]
[2]宋梦姣,韩栋梁,葛宁,等.放疗增敏研究中人卵巢癌SKOV3乏氧细胞模型的建立方法[J].国际放射医学核医学杂志,2014,38(6):356.[doi:10.3760/cma.j.issn.1673-4114.2014.06.002]
Song Meng-jiao,Han Dong-liang,Ge Ning,et al.The method of establishing the hypoxic SKOV3 cellular model in the research of radiotherapy sensitizer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):356.[doi:10.3760/cma.j.issn.1673-4114.2014.06.002]
[3]李鹏,赵卫威,杨建伟.18F-FDG PET-CT在探测卵巢癌术后复发与转移中的应用价值[J].国际放射医学核医学杂志,2012,36(6):348.[doi:10.3760/cma.j.issn.1673-4114.2012.06.007]
LI Peng,ZHAO Wei-wei,YANG Jian-wei.18F-FDG PET-CT imaging in the detection of recurrent and metastasis ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):348.[doi:10.3760/cma.j.issn.1673-4114.2012.06.007]
[4]薛艳,安瑞芳.放射免疫显像在妇科肿瘤中的研究与应用[J].国际放射医学核医学杂志,2006,30(1):36.
XUE Yan,AN Rui-fang.A research on radioimmunoimaging and its application in diagnosis of gynecological tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(1):36.
[5]史文琴.PET显像在卵巢癌诊断中的作用[J].国际放射医学核医学杂志,2001,25(4):158.
SHI Wen-qin.The application of 18F-FDG PET in diagnosing of ovarian carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(1):158.
[6]张伟,于丽娟.18F-FDG PET/CT与18F-FDG PET/MRI在卵巢癌临床应用中的进展[J].国际放射医学核医学杂志,2018,(5):441.[doi:10.3760/cma.j.issn.1673-4114.2018.05.010]
Zhang Wei,Yu Lijuan.Advances in clinical application of 18F-FDG PET/CT and 18F-FDG PET/MRI in ovarian cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(1):441.[doi:10.3760/cma.j.issn.1673-4114.2018.05.010]